US FDA Extends Review Of AstraZeneca’s Experimental Breast Cancer Pill

Published Date: 28 May 2026

AstraZeneca said on Wednesday the U.S. Food and Drug Administration has extended ⁠the decision deadline for the drugmaker's experimental breast cancer pill camizestrant to...

Read Full News

Latest News

HTTP error: 503 HTTP error: 503

News All Time

HTTP error: 503
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chromatin organization linked to p53 tumor suppression mechanism

2.

Despite Medicare Coverage, Cancer Genomic Testing Still Low

3.

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

4.

New protein target discovered for childhood medulloblastomas

5.

CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot